UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PI3K-independent AKT activation in cancers: A treasure trove for novel therapeutics

Journal of cellular physiology, 2012-09, Vol.227 (9), p.3178-3184

2012

Volltextzugriff (PDF)

ACK1/TNK2 Regulates Histone H4 Tyr88-phosphorylation and AR Gene Expression in Castration-Resistant Prostate Cancer

Cancer cell, 2017-06, Vol.31 (6), p.790-803.e8

2017

Volltextzugriff (PDF)

Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer

Nature communications, 2023-06, Vol.14 (1), p.3357-3357, Article 3357

2023

Volltextzugriff (PDF)

Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance

Nature communications, 2022-11, Vol.13 (1), p.6929-6929, Article 6929

2022

Volltextzugriff (PDF)

Shepherding AKT and androgen receptor by Ack1 tyrosine kinase

Journal of cellular physiology, 2010-08, Vol.224 (2), p.327-333

2010

Volltextzugriff (PDF)

Author Correction: Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer

Nature communications, 2023-09, Vol.14 (1), p.6022-6022, Article 6022

2023

Volltextzugriff (PDF)

Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation

PloS one, 2010-03, Vol.5 (3), p.e9646-e9646

2010

Volltextzugriff (PDF)

SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis

Nature communications, 2024-07, Vol.15 (1), p.5629-19, Article 5629

2024

Volltextzugriff (PDF)

Amino Terminal Acetylation of HOXB13 Regulates the DNA Damage Response in Prostate Cancer

Cancers, 2024-05, Vol.16 (9), p.1622

2024

Volltextzugriff (PDF)

Inhibition of ACK1 delays and overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib

Lung cancer (Amsterdam, Netherlands), 2020-12, Vol.150, p.26-35

2020

Volltextzugriff (PDF)

Ack1-mediated Androgen Receptor Phosphorylation Modulates Radiation Resistance in Castration-resistant Prostate Cancer

The Journal of biological chemistry, 2012-06, Vol.287 (26), p.22112-22122

2012

Volltextzugriff (PDF)

Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation

Proceedings of the National Academy of Sciences - PNAS, 2007-05, Vol.104 (20), p.8438-8443

2007

Volltextzugriff (PDF)

Cross talk of tyrosine kinases with the DNA damage signaling pathways

Nucleic acids research, 2015-12, Vol.43 (22), p.10588-10601

2015

Volltextzugriff (PDF)

Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer Development

Cancers, 2024-01, Vol.16 (1), p.213

2024

Volltextzugriff (PDF)

Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity

The Prostate, 2010-09, Vol.70 (12), p.1274-1285

2010

Volltextzugriff (PDF)

Activated tyrosine kinase Ack1 promotes prostate tumorigenesis : Role of Ack1 in polyubiquitination of tumor suppressor Wwox

Cancer research (Chicago, Ill.), 2005-11, Vol.65 (22), p.10514-10523

2005

Volltextzugriff (PDF)

Activated Cdc42-associated Kinase 1 (Ack1) Is Required for Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Receptor Recruitment to Lipid Rafts and Induction of Cell Death

The Journal of biological chemistry, 2013-11, Vol.288 (46), p.32922-32931

2013

Volltextzugriff (PDF)

ACK1 tyrosine kinase: Targeted inhibition to block cancer cell proliferation

Cancer letters, 2013-09, Vol.338 (2), p.185-192

2013

Volltextzugriff (PDF)

Loss of Long Noncoding RNA NXTAR in Prostate Cancer Augments Androgen Receptor Expression and Enzalutamide Resistance

Cancer research (Chicago, Ill.), 2022-01, Vol.82 (1), p.155-168

2022

Volltextzugriff (PDF)

WEE1 tyrosine kinase, a novel epigenetic modifier

Trends in genetics, 2013-07, Vol.29 (7), p.394-402

2013

Volltextzugriff (PDF)

H2B Tyr37 phosphorylation suppresses expression of replication-dependent core histone genes

Nature structural & molecular biology, 2012-09, Vol.19 (9), p.930-937

2012

Volltextzugriff (PDF)

TNK2/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability

Autophagy, 2023-03, Vol.19 (3), p.1000-1025

2023

Volltextzugriff (PDF)

ACK1 Tyrosine Kinase Interacts with Histone Demethylase KDM3A to Regulate the Mammary Tumor Oncogene HOXA1

The Journal of biological chemistry, 2014-10, Vol.289 (41), p.28179-28191

2014

Volltextzugriff (PDF)

Epigenetic underpinnings of tumor-immune dynamics in prostate cancer immune suppression

Trends in Cancer, 2024-04, Vol.10 (4), p.369-381

2024

Volltextzugriff (PDF)

Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach

Cell reports. Medicine, 2023-10, Vol.4 (10), p.101199-101199, Article 101199

2023

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(54)

Sprache

Englisch
(54)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(36)
Humans
(35)
Animals
(23)
Phosphorylation
(21)
Male
(18)
Protein-Tyrosine Kinases - Metabolism
(18)
Prostate Cancer
(17)
Mice
(15)
Cell Line, Tumor
(14)
Oncology
(14)
Biochemistry & Molecular Biology
(12)
Cell Biology
(11)
Epigenetics
(10)
Kinases
(10)
Receptors, Androgen - Metabolism
(10)
Tumors
(10)
Androgens
(9)
Gene Expression
(9)
Protein-Tyrosine Kinases - Genetics
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

PI3K-independent AKT activation in cancers: A treasure trove for novel therapeutics

ACK1/TNK2 Regulates Histone H4 Tyr88-phosphorylation and AR Gene Expression in Castration-Resistant Prostate Cancer

Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer

Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance

Shepherding AKT and androgen receptor by Ack1 tyrosine kinase

Author Correction: Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer

Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation

SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis

Amino Terminal Acetylation of HOXB13 Regulates the DNA Damage Response in Prostate Cancer

Inhibition of ACK1 delays and overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib

Ack1-mediated Androgen Receptor Phosphorylation Modulates Radiation Resistance in Castration-resistant Prostate Cancer

Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation

Cross talk of tyrosine kinases with the DNA damage signaling pathways

Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer Development

Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity

Activated tyrosine kinase Ack1 promotes prostate tumorigenesis : Role of Ack1 in polyubiquitination of tumor suppressor Wwox

Activated Cdc42-associated Kinase 1 (Ack1) Is Required for Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Receptor Recruitment to Lipid Rafts and Induction of Cell Death

ACK1 tyrosine kinase: Targeted inhibition to block cancer cell proliferation

Loss of Long Noncoding RNA NXTAR in Prostate Cancer Augments Androgen Receptor Expression and Enzalutamide Resistance

WEE1 tyrosine kinase, a novel epigenetic modifier

H2B Tyr37 phosphorylation suppresses expression of replication-dependent core histone genes

TNK2/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability

ACK1 Tyrosine Kinase Interacts with Histone Demethylase KDM3A to Regulate the Mammary Tumor Oncogene HOXA1

Epigenetic underpinnings of tumor-immune dynamics in prostate cancer immune suppression

Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach

Suchergebnisse filtern